Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
2 Mooning Stocks on Our Buy List and 1 That Underwhelm

2 Mooning Stocks on Our Buy List and 1 That Underwhelm

CSCO : 77.76 (+0.01%)
UTHR : 484.10 (+0.65%)
HWM : 196.27 (+1.02%)
3 Market-Beating Stocks Worth Your Attention

3 Market-Beating Stocks Worth Your Attention

CECO : 55.62 (+2.06%)
RCL : 259.27 (-2.45%)
UTHR : 484.10 (+0.65%)
The Biotech Boom Gets a Trading Tool: How Direxion's Titans ETF Gives Access to the Sector's Top Performers

Amid the biotechnology sector's transformative era the Direxion Daily Biotech Top 5 Bull 2X ETF ($TBXU) offers traders a new, single-trade solution to gain 2X daily leveraged exposure to an e

ALNY : 465.34 (-1.68%)
EXEL : 44.37 (+0.82%)
GILD : 122.62 (-1.90%)
INSM : 205.04 (-0.84%)
UTHR : 484.10 (+0.65%)
3 Reasons Investors Love United Therapeutics (UTHR)

3 Reasons Investors Love United Therapeutics (UTHR)

UTHR : 484.10 (+0.65%)
The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call

The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call

UTHR : 484.10 (+0.65%)
United Therapeutics Corporation to Present at Upcoming Investor Conferences

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that company executives will provide an overview and update on the company during fireside...

UTHR : 484.10 (+0.65%)
First clinical trial of pig kidney transplants gets underway

The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives

UTHR : 484.10 (+0.65%)
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease

Ongoing EXPAND Study is the First Clinical Trial to Evaluate Xenotransplantation in End-Stage Renal Disease

UTHR : 484.10 (+0.65%)
2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid

2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid

COST : 895.85 (-2.86%)
OGN : 7.14 (-1.79%)
UTHR : 484.10 (+0.65%)
UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook

UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook

UTHR : 484.10 (+0.65%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025?
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar